comparemela.com

Latest Breaking News On - பாயஂட் ஆஃப் பராமரிப்பு சோதனை - Page 5 : comparemela.com

Alarming Rise in Cardiovascular Cases and the Awareness about Early Detection among Many Individuals will Invite Extensive Growth Opportunities for the Cardiac Biomarker Diagnostic Kits Market, Says TMR

EDAN Announces 2020 Annual Results 2025 Outlook: Revenues Increased 104 1%

Share this article Share this article SHENZHEN, China, March 16, 2021 /PRNewswire/ EDAN Instruments, Inc. ( EDAN or the Company) (SHE: 300206) on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its anticipation for 2025. EDAN s 2020 Financial Highlights (all results compared to FY 2019) Revenues increased 104.1% to CNY 2.3 billion, in which CNY 1.4 billion are from Patient Monitoring products with a 270.65% increment compared to FY 2019 Net profit attributed to shareholders reached CNY 653 million vs. CNY 131.3 million Operating income increased 447% to CNY 745 million Net cash from operating activities increased 498% to CNY 689 million

Accreditation agency urges end to subletting of COVID-19 test kits

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.